Katg Therapeutics Private Limited

Katg Therapeutics Private Limited - pharma in Secunderabad, Telangana, India. Directors, charges & compliance details.
CIN U24230TG1996PTC025232 Incorporated 17 September 1996 ROC Hyderabad HQ Secunderabad, Telangana, India
Struck Off Private Limited Company pharma
Data last updated
Revenue · FY 2017
₹27.3 Lakh
Latest filing
Net profit · FY 2017
₹84,031
Net margin 3.1%
EBITDA · FY 2017
₹5.66 Lakh
EBITDA margin 20.8%
Authorised capital
₹30 Lakh
Registered with MCA
Paid-up capital
₹30 Lakh
Issued & subscribed
Satisfied charges
₹1 Cr
No open charges
Company age
30 yrs
Est. 1996
Directors on board
2
As per MCA filings

About Katg Therapeutics Private Limited

Data last updated:

Katg Therapeutics Private Limited was a private limited company based in Secunderabad, Telangana, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 17 September 1996.

The company was registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24230TG1996PTC025232. Its GSTIN is 36AADCK5353L1Z9 (Telangana).

The company had an authorised share capital of ₹30 Lakh and a paid-up capital of ₹30 Lakh. It was led by directors Sudhakar Reddy Kondamareddychinna and Kondamareddy Sarada.

Its last annual general meeting (AGM) was held on 30 September 2022, and its latest financial statements are for the year ended 31 March 2022. The registered office was at 8 – 289 Goutam Nagar Ferozguda, Secunderabad, Telangana, India – 500011.

As per the financials filed for FY 2017, the company reported a revenue of ₹27.3 Lakh. For the same year it recorded a net profit of ₹84,031 (net margin 3.1%) and EBITDA of ₹5.66 Lakh (EBITDA margin 20.8%).

As per MCA filings, the company had satisfied charges of ₹1 Cr on record.

Company details

CIN U24230TG1996PTC025232
Registration Number 025232
Incorporation Date 17 September 1996
ROC Hyderabad
Listing Status Unlisted
Company Status Struck Off
Date of Last AGM 30 September 2022
Date of Balance Sheet 31 March 2022
Compliance Status Active Compliant

CIN history

Katg Therapeutics has one previous CIN (Corporate Identification Number): U24230AP1996PTC025232. The current CIN is U24230TG1996PTC025232, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U24230TG1996PTC025232Current
U24230AP1996PTC025232Previous

Contact details

Katg Therapeutics Private Limited's registered office is in Secunderabad, Telangana. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    8 – 289 Goutam Nagar Ferozguda, Secunderabad, Telangana, India – 500011
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Katg Therapeutics Private Limited, buy the company report.

Comprehensive company report
Katg Therapeutics Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Katg Therapeutics is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

Financials of Katg Therapeutics Private Limited

FY 2022 filings available

Katg Therapeutics Private Limited reported revenue of ₹27.3 Lakh for FY 2017.

Revenue · FY 2017
₹27.3 Lakh
Net profit · FY 2017
₹84,031 margin 3.1%
EBITDA · FY 2017
₹5.66 Lakh margin 20.8%

Financial Statement Summary

MetricsFY 2016-17FY 2015-16FY 2014-15
Profit and Loss Statement
Revenue from Operations₹27.3 Lakh
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹5.66 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹84,031
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2016-17FY 2015-16FY 2014-15
Profitability
EBITDA Margin20.8%
Net Profit Margin3.1%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Katg Therapeutics Private Limited, buy the company report.

Board of directors of Katg Therapeutics Private Limited

Katg Therapeutics has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.

Directors (as last reported)
NameDesignationAppointment DateTenureStatus
Sudhakar Reddy KondamareddychinnaDirector17 Sep 199630 Years 1 MonthsAs last reported
Kondamareddy SaradaDirector27 Mar 200224 Years 7 MonthsAs last reported

Auditor

Katg Therapeutics Private Limited is audited by H SATYANARAYANA REDDY & CO for the financial year 2017.

Auditor firmFinancial yearFirm registration number
H SATYANARAYANA REDDY & COFY 2017005644S

Shareholding

The shareholding of Katg Therapeutics Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2017FY 2016
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Katg Therapeutics Private Limited, buy the company report.

Charges & borrowings

Open charges
None
Satisfied charges
₹1 Cr
Breakdown by lending institutions
Bank of Baroda₹1.00 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
07 Aug 200610015697Bank of Baroda₹1 CrSatisfied

To see the full charge records of Katg Therapeutics Private Limited, buy the company report.

Total charge records: 1 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Katg Therapeutics Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Katg Therapeutics has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
36AADCK5353L1Z9TelanganaActive01 Jul 2017

To see the full GST registrations and return filing status of Katg Therapeutics Private Limited, buy the company report.

Recent activity

Katg Therapeutics Private Limited has 4 board changes on record since 1996: 2 appointments and 2 cessations. The latest: Ravi Kiran Kondamareddy ceased to be Director on 10 Sep 2018.

AGM
Katg Therapeutics Private Limited last Annual general meeting of members was held on 30 Sep 2022 as per latest MCA records.
Filing
Katg Therapeutics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Hyderabad.
Ceased
Ravi Kiran Kondamareddy ceased to be Director.
Ceased
Sudhakar Andalamala ceased to be Director.
Charges
A charge registered on 07 Aug 2006 via Charge ID 10015697 with Bank Of Baroda was fully satisfied on 05 Jan 2008.
Charges
A charge with Bank Of Baroda amounted to Rs. 100.00 Lakh with Charge ID 10015697 was registered on 07 Aug 2006.
Appointed
Kondamareddy Sarada was appointed as Director.
Appointed
Sudhakar Reddy Kondamareddychinna was appointed as Director.
Incorporation
17 Sep 1996
Katg Therapeutics Private Limited was registered on 17 Sep 1996 with Roc Hyderabad & aged 30 years 1 month as per MCA records.

Frequently asked questions

Katg Therapeutics has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.

Katg Therapeutics was a private limited company based in Secunderabad, Telangana, India. The company worked in drug formulation and development, within the pharma industry. It was incorporated on 17 September 1996 and is registered under CIN U24230TG1996PTC025232. The company has been struck off by the Registrar of Companies and is no longer operational.

Katg Therapeutics had 2 directors:

The CIN (Corporate Identification Number) of Katg Therapeutics is U24230TG1996PTC025232. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

The registered office of Katg Therapeutics is at 8 – 289 Goutam Nagar Ferozguda, Secunderabad, Telangana, India – 500011.

Katg Therapeutics was incorporated on 17 September 1996. It is registered with the Registrar of Companies, Hyderabad.

The latest financial statements of Katg Therapeutics on record with the MCA are for the year ended 31 March 2022. Its last annual general meeting was held on 30 September 2022. Year-wise statements from 2015 are in the company report.

The GSTIN of Katg Therapeutics is 36AADCK5353L1Z9, registered in Telangana.

Katg Therapeutics operated in the pharma industry, in the drug formulation and development segment. It worked in this industry before it was struck off.

Ravi Kiran Kondamareddy ceased to be Director on 10 Sep 2018. Sudhakar Andalamala ceased to be Director on 10 Jul 2015. Kondamareddy Sarada was appointed as Director on 27 Mar 2002. Katg Therapeutics has 4 board changes on record in total.